Haring-Layton MarDee 4
4 · Dare Bioscience, Inc. · Filed Jan 31, 2025
Insider Transaction Report
Form 4
Haring-Layton MarDee
Chief Accounting Officer
Transactions
- Award
Employee Stock Option (right to buy)
2025-01-28+38,000→ 38,000 totalExercise: $3.27Exp: 2035-01-28→ Common stock (38,000 underlying)
Footnotes (1)
- [F1]This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer.